Exagen Inc. XGN EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s EPS (diluted)?
- Exagen Inc. (XGN) reported EPS (diluted) of -$0.17 in Q1 2026.
- How has Exagen Inc.'s EPS (diluted) changed year-over-year?
- Exagen Inc.'s EPS (diluted) increased by 15.0% year-over-year, from -$0.20 to -$0.17.
- What is the long-term trend for Exagen Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Exagen Inc.'s EPS (diluted) has grown at a -14.1% compound annual growth rate (CAGR), from -$1.69 to -$0.92.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.